Shanghai Haohai Biological Technology Co Ltd
SSE:688366
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
56.02
113.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Shanghai Haohai Biological Technology Co Ltd
Shanghai Haohai Biological Technology Co Ltd
Additional Paid In Capital
Shanghai Haohai Biological Technology Co Ltd
Additional Paid In Capital Peer Comparison
6160
603392
002252
300122
300896
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
|
Additional Paid In Capital
¥3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Additional Paid In Capital
¥81.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Additional Paid In Capital
¥3.3B
|
CAGR 3-Years
95%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Additional Paid In Capital
¥13.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
35%
|
CAGR 10-Years
20%
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Additional Paid In Capital
¥3.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
90%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Haohai Biological Technology Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
3B
CNY
Based on the financial report for Dec 31, 2023, Shanghai Haohai Biological Technology Co Ltd's Additional Paid In Capital amounts to 3B CNY.
What is Shanghai Haohai Biological Technology Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
11%
Over the last year, the Additional Paid In Capital growth was -1%. The average annual Additional Paid In Capital growth rates for Shanghai Haohai Biological Technology Co Ltd have been -3% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
